Company’s share stock price set at PLN 11

The Management Board of Genomtec S.A. is pleased to inform that the series J share price has been set at PLN 11 per share. The issuing shares’ ... More

Smart Growth Operational Programme 2014-2020 – “Fast Track”

Project title:Developing a portable diagnostic device based on lab-on-chip analysis system to detect COVID-19 disease (SARS-CoV-2 pathogen). ... More

Genomtec starts public offer

Genomtec S.A. has launched an initial public offering of up to 730,000 J-series shares. The maximum price per share was agreed at PLN 11. The ... More

Genomtec S.A. presents its flagship diagnostic platform – Genomtec ID

Work on the mobile diagnostic platform – Genomtec ID, began in 2017 and currently we are starting its industrialization, proudly presenting ... More

Genomtec S.A. is being strengthened by joining key personnel – welcome to Jarek Oleszczuk, M.D., PhD, Marta Gajęcka and Jakub Swadźba, M.D., PhD.

Due to the dynamic growth in space the of company’s flagship project – Genomtec ID, the Management Board, fulfilling expectations of its ... More

Our plan is to debut on the NewConnect market, the Warsaw Stock Exchange, by the end of 2020 year

We would like to kindly inform you on our plans to adjust Company’s organizational structure to comply with all the conditional regulatory ... More